The present invention describes an approach to cancer therapy utilizing novel VEGF receptor antagonists. Specifically, the invention provides peptides and polynucleotides encoding VEGF receptor antagonists and methods of use thereof.

 
Web www.patentalert.com

< Synergistic mixtures of 1,2-alkane diols

> Feline immunoglobulin E molecules and related methods

> Prevention and treatment of synucleinopathic and amyloidogenic disease
~ 00539